Is Bright Minds Biosciences Inc (DRUG) a Poor Choice in the Healthcare Sector?

A rating of 9 puts Bright Minds Biosciences Inc (DRUG) near the top of the Healthcare sector according to InvestorsObserver. Bright Minds Biosciences Inc's score of 9 means that it ranks higher than 9% of stocks in the sector. In addition, its overall score of 7 ranks it higher than 7% of all stocks.

DRUG has an Overall Score of 7. Find out what this means to you and get the rest of the rankings on DRUG!

See Full DRUG Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 7 means the stock is more attractive than 7 percent of stocks. Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Bright Minds Biosciences Inc Stock Today?

Bright Minds Biosciences Inc (DRUG) stock is trading at $1.99 as of 2:50 PM on Tuesday, Jan 9, an increase of $0.11, or 5.85% from the previous closing price of $1.88. The stock has traded between $1.91 and $2.18 so far today. Volume today is elevated. So far 96,582 shares have traded compared to average volume of 42,552 shares. Click Here to get the full Stock Report for Bright Minds Biosciences Inc stock.